You are here: Industry Insights > COVID-19

News List

FDA clears Appili Therapeutics to expand its trial of favipiravir for prrevention of Covid-19 pharmaceutical-business-review
August 13, 2020
Appili Therapeutics, a biopharmaceutical company focused on anti-infective drug development, today announced that the U.S. Food and Drug Administration (FDA) has granted the Company clearance to proceed after Appili’s filing of ...
Only 79% of Americans Considering Getting Coronavirus Vaccine According to ValuePenguin.com Survey prnewswire
August 13, 2020
As the race to find a vaccine for the coronavirus continues, and news out of Russia hints at a possible COVID-19 vaccination win, ValuePenguin wanted to know how the American people view vaccinations and whether or not ...
Scientists identify hundreds of drug candidates to treat COVID-19 worldpharmanews
August 13, 2020
Scientists at the University of California, Riverside, have used machine learning to identify hundreds of new potential drugs that could help treat COVID-19, the disease caused by the novel coronavirus, or SARS-CoV-2.
Two Phase III trials in US to evaluate efficacy of mAbs against COVID-19 europeanpharmaceuticalreview
August 13, 2020
Two randomised Phase III clinical trials to test mAbs against COVID-19 are now enrolling healthy adults in the US, the NIH has announced.
Demand for mental health services to rise due to COVID-19, report finds pharmatimes
August 13, 2020
A report from the NHS Confederation has forecast that the peak in demand for mental healthcare in England is yet to come as the effects of the coronavirus pandemic continue to have an impact.
Enlivex Announces First Patient Dosed in Allocetra Trial for COVID-19 with Respiratory Failure americanpharmaceuticalreview
August 13, 2020
Enlivex Therapeutics announced the first patient has been dosed in an investigator-initiated multi-center clinical trial of AllocetraTM in COVID-19 patients with severe illness and respiratory failures.
Beroni Signs Agreement with CDMO Genscript Biotech contractpharma
August 13, 2020
To conduct further study to develop nanobody-based medical solution for COVID-19.
Mission Atma Nirbhar in pharma expresspharma
August 13, 2020
Let us keep in mind that India is not a weak economy. We are a strong economy. Despite pressure due to COVID-19, terrorist problem and threat of war from China, India has proven its strength.
Remdesivir shortage is India is easing: Cipla expresspharma
August 13, 2020
The company has informed that it has started producing remdesivir at a plant in Goa in western India to ramp up production.
Stanford study reveals immune-system deviations in severe COVID-19 cases expresspharma
August 13, 2020
The study revealed, paradoxically, that the worse the case of COVID-19, the less effective certain cells of the innate immune system were in responding to the disease.